Cryoport affiliate files Form 144 for option-linked sales
Cryoport, Inc. affiliate submitted a Form 144 reporting proposed sales of Common Stock tied to multiple stock option lots.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cryoport, Inc. affiliate submitted a Form 144 reporting proposed sales of Common Stock tied to multiple stock option lots. The filing lists option lots of 47,812, 53,334, 20,000, 16,864, 16,000, 5,000, and 10,417 shares with grant dates ranging from 06/01/2021 to 12/11/2024
The Form 144 is a notice of intended resale by an affiliate under regulatory procedures; the filing lists the securities to be sold but does not state executed transaction proceeds or timing.
Insights
Form 144 lists proposed option-related resales by an affiliate; this is a regulatory resale notice, not a trade confirmation.
The filing enumerates multiple stock option lots (grant dates and quantities are shown). Form 144 provides notice under resale rules and signals the affiliate intends to sell shares derived from option exercises.
Timing and proceeds are not disclosed; subsequent filings (Form 4 or trade confirmations) would show executed sales and cash-flow treatment when they occur.
Key Figures
Key Terms
Form 144 regulatory
Stock Options financial
Securities To Be Sold regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Cryoport (CYRX) Form 144 report?
How many option lots are listed in the CYRX Form 144?
Will Form 144 disclose sale proceeds or timing for CYRX?
Are the listed securities in CYRX Form 144 common stock or options?
AI-generated analysis. How Rhea-AI works. Not financial advice.